| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.486 | 0.005 | 0.486 | Lipid peroxidase inhibitor | 0.17 0.055 CID_154699603 | ||
| 0.444 | 0.003 | 0.444 | UDP-N-acetylglucosamine 1-carboxyvinyltransferase inhibitor | 0.362 0.004 CID_154699603 | ||
| 0.437 | 0.004 | 0.437 | UDP-glucose 4-epimerase inhibitor | |||
| 0.444 | 0.031 | 0.444 | Caspase 3 stimulant | |||
| 0.422 | 0.067 | 0.422 | Calcium channel L-type activator | |||
| 0.365 | 0.041 | 0.365 | Calcium channel activator | |||
| 0.361 | 0.038 | 0.361 | DNA damaging | |||
| 0.315 | 0.019 | 0.315 | Glyceraldehyde-3-phosphate dehydrogenase inhibitor | |||
| 0.301 | 0.011 | 0.301 | Nitric-oxide synthase stimulant | |||
| 0.397 | 0.113 | 0.397 | Caspase 9 stimulant | |||
| 0.279 | 0.014 | 0.279 | Aldehyde dehydrogenase inhibitor | 0.156 0.044 CID_154699603 | ||
| 0.28 | 0.023 | 0.28 | MAO inhibitor | |||
| 0.304 | 0.049 | 0.483 | Superoxide dismutase inhibitor | 0.483 0.015 CID_154699603 | CID_154699603 | |
| 0.256 | 0.005 | 0.256 | TRPA1 agonist | |||
| 0.376 | 0.126 | 0.376 | DNA directed DNA polymerase inhibitor | |||
| 0.277 | 0.047 | 0.277 | 5 Hydroxytryptamine 1E antagonist | |||
| 0.238 | 0.01 | 0.615 | Histidine decarboxylase inhibitor | 0.615 0.002 CID_154699603 | CID_154699603 | |
| 0.262 | 0.042 | 0.262 | DNA methyltransferase I inhibitor | 0.191 0.074 CID_154699603 | ||
| 0.232 | 0.016 | 0.232 | Ferrochelatase inhibitor | |||
| 0.27 | 0.055 | 0.27 | DNA synthesis inhibitor | |||
| 0.226 | 0.011 | 0.226 | Breast cancer-resistant protein inhibitor | |||
| 0.229 | 0.019 | 0.229 | MAO B inhibitor | |||
| 0.213 | 0.004 | 0.213 | Thioredoxin reductase inhibitor | |||
| 0.211 | 0.009 | 0.211 | Urease inhibitor | 0.125 0.04 CID_154699603 | ||
| 0.26 | 0.059 | 0.26 | Tyrosine 3 hydroxylase inhibitor | 0.22 0.104 CID_154699603 | ||
| 0.222 | 0.021 | 0.239 | Alkylator | 0.239 0.018 CID_154699603 | CID_154699603 | |
| 0.254 | 0.061 | 0.29 | Calpain inhibitor | 0.29 0.035 CID_154699603 | CID_154699603 | |
| 0.204 | 0.012 | 0.204 | Alcohol dehydrogenase inhibitor | 0.124 0.032 CID_154699603 | ||
| 0.243 | 0.052 | 0.27 | DNA methylase inhibitor | 0.27 0.038 CID_154699603 | CID_154699603 | |
| 0.207 | 0.017 | 0.207 | Histone deacetylase class III inhibitor | 0.192 0.022 CID_154699603 | ||
| 0.196 | 0.007 | 0.559 | Glutamate decarboxylase inhibitor | 0.559 0.002 CID_154699603 | CID_154699603 | |
| 0.2 | 0.011 | 0.2 | Triose-phosphate isomerase inhibitor | |||
| 0.212 | 0.029 | 0.212 | Hexokinase inhibitor | |||
| 0.203 | 0.021 | 0.203 | Cathepsin H inhibitor | 0.18 0.029 CID_154699603 | ||
| 0.183 | 0.01 | 0.183 | DOPA decarboxylase inhibitor | 0.096 0.085 CID_154699603 | ||
| 0.215 | 0.043 | 0.215 | 3C-like protease (Human coronavirus) inhibitor | |||
| 0.174 | 0.006 | 0.174 | Histone deacetylase SIRT2 inhibitor | |||
| 0.2 | 0.032 | 0.2 | Anesthetic local | |||
| 0.208 | 0.043 | 0.208 | Succinate dehydrogenase inhibitor | |||
| 0.197 | 0.032 | 0.197 | Mannose-6-phosphate isomerase inhibitor | |||
| 0.192 | 0.028 | 0.192 | Topoisomerase I inhibitor | |||
| 0.171 | 0.016 | 0.171 | Porphobilinogen synthase inhibitor | |||
| 0.269 | 0.115 | 0.269 | Vasodilator, coronary | |||
| 0.173 | 0.02 | 0.228 | Adenylate kinase inhibitor | 0.228 0.012 CID_154699603 | CID_154699603 | |
| 0.164 | 0.015 | 0.164 | NAD(P)H dehydrogenase (quinone) inhibitor | |||
| 0.167 | 0.018 | 0.167 | Androgen antagonist | |||
| 0.273 | 0.133 | 0.378 | Calpain 2 inhibitor | 0.378 0.073 CID_154699603 | CID_154699603 | |
| 0.321 | 0.185 | 0.321 | Ca2+/calmodulin-dependent protein kinase kinase A inhibitor | |||
| 0.164 | 0.032 | 0.625 | Aminopeptidase B inhibitor | 0.625 0.002 CID_154699603 | CID_154699603 | |
| 0.133 | 0.012 | 0.133 | Biliverdin reductase inhibitor | |||
| 0.131 | 0.01 | 0.131 | Human rhinovirus A protease inhibitor | 0.054 0.039 CID_154699603 | ||
| 0.144 | 0.024 | 0.144 | Calcium antagonist | |||
| 0.225 | 0.109 | 0.225 | 5 Hydroxytryptamine uptake stimulant | |||
| 0.143 | 0.028 | 0.143 | HIV-1 integrase (Overall Integration) inhibitor | |||
| 0.194 | 0.084 | 0.194 | Pyruvate kinase inhibitor | |||
| 0.146 | 0.037 | 0.146 | Sphingosine 1-phosphate receptor 4 antagonist | |||
| 0.186 | 0.082 | 0.186 | Anesthetic general | |||
| 0.121 | 0.018 | 0.121 | Aromatase inhibitor | |||
| 0.201 | 0.099 | 0.201 | Glucose-6-phosphate dehydrogenase-6-phosphogluconolactonase inhibitor | |||
| 0.112 | 0.011 | 0.112 | Androgen agonist | |||
| 0.172 | 0.072 | 0.172 | Sigma receptor agonist | |||
| 0.232 | 0.141 | 0.232 | Transcription factor NF kappa B inhibitor | 0.229 0.143 CID_154699603 | ||
| 0.235 | 0.145 | 0.235 | Thioredoxin glutathione reductase inhibitor | |||
| 0.116 | 0.026 | 0.116 | Phosphofructokinase-1 inhibitor | 0.059 0.057 CID_154699603 | ||
| 0.133 | 0.044 | 0.169 | Caspase 3 inhibitor | 0.169 0.017 CID_154699603 | CID_154699603 | |
| 0.129 | 0.044 | 0.129 | GABA C receptor agonist | |||
| 0.155 | 0.07 | 0.432 | Phospholipase A2 inhibitor | 0.432 0.004 CID_154699603 | CID_154699603 | |
| 0.143 | 0.059 | 0.143 | Alpha-N-acetylglucosaminidase inhibitor | |||
| 0.148 | 0.065 | 0.148 | Sphingosine 1-phosphate receptor 5 antagonist | |||
| 0.105 | 0.024 | 0.105 | D-Ala-D-Ala ligase inhibitor | |||
| 0.121 | 0.04 | 0.121 | Creatine kinase inhibitor | |||
| 0.091 | 0.01 | 0.091 | Oleamide hydrolase inhibitor | |||
| 0.096 | 0.021 | 0.096 | Carbonic anhydrase IX inhibitor | |||
| 0.135 | 0.062 | 0.135 | Antibacterial (Helicobacter pylori) | |||
| 0.08 | 0.007 | 0.08 | Fructose-1,6-bisphosphatase inhibitor | |||
| 0.093 | 0.021 | 0.093 | Carbonic anhydrase XII inhibitor | |||
| 0.149 | 0.078 | 0.149 | CF transmembrane conductance regulator agonist | |||
| 0.078 | 0.007 | 0.078 | Fumarate hydratase inhibitor | |||
| 0.093 | 0.023 | 0.093 | GABA B receptor agonist | |||
| 0.156 | 0.087 | 0.259 | Neurotensin receptor agonist | 0.259 0.02 CID_154699603 | CID_154699603 | |
| 0.126 | 0.058 | 0.148 | Monophenol monooxygenase inhibitor | 0.148 0.048 CID_154699603 | CID_154699603 | |
| 0.087 | 0.022 | 0.087 | Alcohol oxidase inhibitor | |||
| 0.096 | 0.03 | 0.096 | GABA aminotransferase inhibitor | |||
| 0.1 | 0.037 | 0.96 | Glutathione S-transferase inhibitor | 0.96 0.001 CID_154699603 | CID_154699603 | |
| 0.127 | 0.065 | 0.127 | M18 aspartyl aminopeptidase inhibitor | |||
| 0.086 | 0.023 | 0.097 | Protease 3C (Human rhinovirus) inhibitor | 0.097 0.017 CID_154699603 | CID_154699603 | |
| 0.091 | 0.03 | 0.091 | Sphingosine 1-phosphate receptor 4 agonist | 0.068 0.046 CID_154699603 | ||
| 0.083 | 0.024 | 0.083 | Carbonic anhydrase I inhibitor | |||
| 0.082 | 0.024 | 0.082 | Purinergic P2X1 antagonist | |||
| 0.139 | 0.082 | 0.489 | Thiol protease inhibitor | 0.489 0.01 CID_154699603 | CID_154699603 | |
| 0.063 | 0.006 | 0.063 | Glutamate (mGluR8) agonist | 0.063 0.006 CID_154699603 | ||
| 0.229 | 0.174 | 0.229 | GABA C receptor rho-3 antagonist | |||
| 0.107 | 0.055 | 0.107 | Carbonic anhydrase III inhibitor | |||
| 0.069 | 0.018 | 0.069 | Dihydroorotate oxidase inhibitor | |||
| 0.074 | 0.024 | 0.074 | Transcription factor RelA inhibitor | |||
| 0.174 | 0.124 | 0.174 | 5 Hydroxytryptamine 3E antagonist | |||
| 0.076 | 0.026 | 0.098 | Nitric oxide donor | 0.098 0.009 CID_154699603 | CID_154699603 | |
| 0.099 | 0.05 | 0.099 | Thioredoxin inhibitor | 0.087 0.067 CID_154699603 | ||
| 0.116 | 0.067 | 0.116 | Interleukin 8 antagonist | 0.103 0.09 CID_154699603 | ||
| 0.083 | 0.034 | 0.083 | Carbonic anhydrase inhibitor | |||
| 0.078 | 0.03 | 0.078 | NMDA receptor glycine site agonist | 0.069 0.037 CID_154699603 | ||
| 0.075 | 0.027 | 0.075 | Carbonic anhydrase II inhibitor | |||
| 0.055 | 0.008 | 0.055 | Heme oxygenase inhibitor | |||
| 0.101 | 0.055 | 0.101 | Phosphodiesterase 7B inhibitor | |||
| 0.081 | 0.035 | 0.081 | S-adenosyl-L-methionine decarboxylase inhibitor | |||
| 0.124 | 0.079 | 0.124 | Amylase inhibitor | |||
| 0.059 | 0.014 | 0.059 | Glutamate (mGluR4) antagonist | 0.055 0.017 CID_154699603 | ||
| 0.162 | 0.117 | 0.222 | Insulin sensitizer | 0.222 0.054 CID_154699603 | CID_154699603 | |
| 0.136 | 0.091 | 0.136 | Ca2+-transporting ATPase inhibitor | |||
| 0.087 | 0.043 | 0.087 | CYP2A6 inhibitor | |||
| 0.056 | 0.013 | 0.056 | Dihydrofolate reductase inhibitor | |||
| 0.06 | 0.017 | 0.125 | Thymidylate synthase inhibitor | 0.125 0.004 CID_154699603 | CID_154699603 | |
| 0.056 | 0.013 | 0.071 | Kainate receptor 2 antagonist | 0.071 0.009 CID_154699603 | CID_154699603 | |
| 0.073 | 0.03 | 0.118 | NMDA 2C receptor antagonist | 0.118 0.011 CID_154699603 | CID_154699603 | |
| 0.048 | 0.008 | 0.048 | NMDA 2D receptor antagonist | |||
| 0.062 | 0.021 | 0.076 | Lysophosphatidic acid 3 receptor antagonist | 0.076 0.011 CID_154699603 | CID_154699603 | |
| 0.054 | 0.013 | 0.115 | AMPA 4 receptor antagonist | 0.115 0.004 CID_154699603 | CID_154699603 | |
| 0.07 | 0.03 | 0.072 | Argininosuccinate synthase inhibitor | 0.072 0.029 CID_154699603 | CID_154699603 | |
| 0.103 | 0.062 | 0.103 | MAO A inhibitor | |||
| 0.059 | 0.019 | 0.059 | NMDA receptor subunit 3B antagonist | 0.042 0.033 CID_154699603 | ||
| 0.052 | 0.012 | 0.052 | Kainate receptor agonist | 0.043 0.025 CID_154699603 | ||
| 0.189 | 0.15 | 0.189 | Transcription factor STAT3 inhibitor | |||
| 0.079 | 0.041 | 0.079 | Calcium channel L-type blocker | |||
| 0.057 | 0.019 | 0.057 | Dopamine beta hydroxylase inhibitor | |||
| 0.064 | 0.027 | 0.064 | Ryanodine receptor antagonist | |||
| 0.176 | 0.139 | 0.176 | RNA-directed DNA polymerase inhibitor | |||
| 0.061 | 0.025 | 0.061 | Nicotinic alpha3beta2 receptor antagonist | |||
| 0.046 | 0.01 | 0.046 | Catechol O-methyltransferase inhibitor | |||
| 0.057 | 0.021 | 0.057 | Estradiol 17 beta-dehydrogenase inhibitor | |||
| 0.071 | 0.036 | 0.071 | Beta adrenoreceptor antagonist | |||
| 0.132 | 0.097 | 0.132 | Neuropeptide Y1 antagonist | |||
| 0.096 | 0.062 | 0.096 | Lanosterol 14 alpha demethylase inhibitor | |||
| 0.08 | 0.045 | 0.24 | Glutamate dehydrogenase inhibitor | 0.24 0.008 CID_154699603 | CID_154699603 | |
| 0.177 | 0.144 | 0.177 | 5 Hydroxytryptamine release stimulant | |||
| 0.05 | 0.019 | 0.05 | Urate transporter 1 inhibitor | |||
| 0.07 | 0.039 | 0.07 | MDM2 inhibitor | |||
| 0.122 | 0.092 | 0.122 | Sphingosine 1-phosphate receptor 2 antagonist | |||
| 0.066 | 0.04 | 0.066 | Beta 3 adrenoreceptor antagonist | |||
| 0.106 | 0.08 | 0.106 | Microtubule formation inhibitor | |||
| 0.189 | 0.164 | 0.189 | 12-Lipoxygenase inhibitor | |||
| 0.034 | 0.01 | 0.034 | Estradiol 17 beta-dehydrogenase 1 inhibitor | |||
| 0.104 | 0.081 | 0.163 | Proteasome inhibitor | 0.163 0.039 CID_154699603 | CID_154699603 | |
| 0.031 | 0.008 | 0.031 | Acid ceramidase inhibitor | |||
| 0.056 | 0.033 | 0.056 | Alpha-mannosidase inhibitor | |||
| 0.069 | 0.047 | 0.069 | Carbonic anhydrase VA inhibitor | |||
| 0.204 | 0.182 | 0.388 | Interleukin 2 agonist | 0.388 0.031 CID_154699603 | CID_154699603 | |
| 0.053 | 0.03 | 0.053 | Potassium channel (Inward rectifier) activator | |||
| 0.047 | 0.025 | 0.047 | Glutamate (mGluR group III) antagonist | |||
| 0.056 | 0.034 | 0.245 | Ornithine carbamoyltransferase inhibitor | 0.245 0.005 CID_154699603 | CID_154699603 | |
| 0.047 | 0.026 | 0.11 | AICAR transformylase inhibitor | 0.11 0.004 CID_154699603 | CID_154699603 | |
| 0.068 | 0.047 | 0.068 | Exportin-1 inhibitor | |||
| 0.05 | 0.029 | 0.05 | Potassium channel (ATP-sensitive) activator | |||
| 0.036 | 0.016 | 0.076 | AMPA 3 receptor antagonist | 0.076 0.005 CID_154699603 | CID_154699603 | |
| 0.063 | 0.043 | 0.167 | NMDA receptor agonist | 0.167 0.006 CID_154699603 | CID_154699603 | |
| 0.097 | 0.077 | 0.18 | Factor V inhibitor | 0.18 0.008 CID_154699603 | CID_154699603 | |
| 0.044 | 0.026 | 0.157 | Kainate receptor antagonist | 0.157 0.004 CID_154699603 | CID_154699603 | |
| 0.043 | 0.025 | 0.043 | 3-Hydroxyanthranilate 3,4-dioxygenase inhibitor | |||
| 0.031 | 0.014 | 0.031 | Estrogen-related receptor gamma antagonist | |||
| 0.046 | 0.03 | 0.046 | Mannosidase inhibitor | |||
| 0.041 | 0.025 | 0.041 | Dihydropteroate synthase inhibitor | |||
| 0.05 | 0.035 | 0.138 | CD45 antagonist | 0.138 0.006 CID_154699603 | CID_154699603 | |
| 0.033 | 0.018 | 0.154 | AMPA 1 receptor antagonist | 0.154 0.004 CID_154699603 | CID_154699603 | |
| 0.055 | 0.039 | 0.055 | Immunoglobulin Fc receptor antagonist | |||
| 0.048 | 0.033 | 0.048 | AMPA receptor antagonist | |||
| 0.027 | 0.013 | 0.027 | Complement factor 1s inhibitor | |||
| 0.059 | 0.045 | 0.059 | TRPA1 antagonist | |||
| 0.038 | 0.025 | 0.038 | Glucose-6-phosphate dehydrogenase inhibitor | |||
| 0.156 | 0.143 | 0.156 | Cyclic AMP phosphodiesterase inhibitor | |||
| 0.149 | 0.136 | 0.149 | Aryl hydrocarbon receptor agonist | |||
| 0.062 | 0.05 | 0.062 | Calcium channel P-type blocker | |||
| 0.027 | 0.015 | 0.03 | Kainate receptor 4 antagonist | 0.03 0.014 CID_154699603 | CID_154699603 | |
| 0.022 | 0.011 | 0.022 | Factor XIII inhibitor | |||
| 0.018 | 0.007 | 0.018 | Thromboxane A2 agonist | |||
| 0.038 | 0.026 | 0.038 | Potassium channel Kv1.1 blocker | |||
| 0.045 | 0.034 | 0.045 | Purinergic P2X4 antagonist | |||
| 0.04 | 0.029 | 0.04 | Phenylethanolamine N methyltransferase inhibitor | |||
| 0.026 | 0.016 | 0.026 | Lysophosphatidic acid receptor 1 agonist | |||
| 0.045 | 0.034 | 0.045 | Carbonic anhydrase VII inhibitor | |||
| 0.037 | 0.027 | 0.037 | NMDA receptor subunit 3A antagonist | |||
| 0.089 | 0.079 | 0.089 | Anabolic | |||
| 0.034 | 0.025 | 0.034 | Adenosine uptake inhibitor | |||
| 0.06 | 0.053 | 0.06 | Carbonic anhydrase V inhibitor | |||
| 0.057 | 0.05 | 0.057 | Enoyl-[acyl-carrier-protein] reductase inhibitor | |||
| 0.183 | 0.176 | 0.183 | Thyroid hormone antagonist | |||
| 0.054 | 0.047 | 0.054 | 3-Oxoacyl-[acyl-carrier-protein] synthase inhibitor | |||
| 0.072 | 0.066 | 0.072 | Sphingosine 1-phosphate receptor antagonist | |||
| 0.023 | 0.017 | 0.023 | Fructose-1,6-bisphosphatase 1 inhibitor | |||
| 0.035 | 0.029 | 0.035 | Integrin alpha2 antagonist | |||
| 0.021 | 0.015 | 0.023 | Human T-cell leukemia virus type I protease inhibitor | 0.023 0.013 CID_154699603 | CID_154699603 | |
| 0.074 | 0.068 | 0.074 | Glycine receptor antagonist | |||
| 0.046 | 0.041 | 0.146 | NMDA 2A receptor antagonist | 0.146 0.007 CID_154699603 | CID_154699603 | |
| 0.012 | 0.009 | 0.013 | Glutamate (mGluR6) agonist | 0.013 0.008 CID_154699603 | CID_154699603 | |
| 0.103 | 0.1 | 0.103 | Transcription factor STAT6 inhibitor | |||
| 0.039 | 0.036 | 0.039 | Histamine H2 receptor agonist | |||
| 0.123 | 0.121 | 0.123 | Arachidonic acid antagonist | |||
| 0.242 | 0.24 | 0.242 | 5 Hydroxytryptamine release inhibitor | |||
| 0.018 | 0.017 | 0.018 | Progesterone receptor B antagonist | |||
| 0.035 | 0.034 | 0.064 | Membrane dipeptidase inhibitor | 0.064 0.009 CID_154699603 | CID_154699603 | |
| 0.015 | 0.015 | 0.021 | Kainate receptor 3 antagonist | 0.021 0.009 CID_154699603 | CID_154699603 | |
| 0.077 | 0.078 | 0.083 | 3C-Like protease (SARS coronavirus) inhibitor | 0.083 0.06 CID_154699603 | CID_154699603 | |
| 0.023 | 0.024 | 0.059 | Lysine carboxypeptidase inhibitor | 0.059 0.006 CID_154699603 | CID_154699603 | |
| 0.051 | 0.054 | 0.084 | Botulinum neurotoxin type A inhibitor | 0.084 0.015 CID_154699603 | CID_154699603 | |
| 0.016 | 0.02 | 0.035 | Kainate receptor 1 antagonist | 0.035 0.008 CID_154699603 | CID_154699603 | |
| 0.043 | 0.048 | 0.065 | Collagenase inhibitor | 0.065 0.012 CID_154699603 | CID_154699603 | |
| 0.155 | 0.162 | 0.312 | Interleukin agonist | 0.312 0.042 CID_154699603 | CID_154699603 | |
| 0.061 | 0.068 | 0.188 | Aminopeptidase I inhibitor | 0.188 0.008 CID_154699603 | CID_154699603 | |
| 0.103 | 0.111 | 0.111 | Alkaline phosphatase inhibitor | 0.111 0.097 CID_154699603 | CID_154699603 | |
| 0.022 | 0.03 | 0.052 | AMPA 2 receptor antagonist | 0.052 0.011 CID_154699603 | CID_154699603 | |
| 0.014 | 0.023 | 0.022 | Kainate receptor 5 antagonist | 0.022 0.013 CID_154699603 | CID_154699603 | |
| 0.067 | 0.078 | 0.102 | Chymotrypsin inhibitor | 0.102 0.035 CID_154699603 | CID_154699603 | |
| 0.132 | 0.149 | 0.592 | Phospholipase C inhibitor | 0.592 0.004 CID_154699603 | CID_154699603 | |
| 0.033 | 0.053 | 0.105 | Antimetabolite | 0.105 0.015 CID_154699603 | CID_154699603 | |
| 0.144 | 0.167 | 0.237 | Vasodilator | 0.237 0.077 CID_154699603 | CID_154699603 | |
| 0.039 | 0.062 | 0.1 | Bombesin 2 receptor antagonist | 0.1 0.014 CID_154699603 | CID_154699603 | |
| 0.022 | 0.047 | 0.053 | Methionyl aminopeptidase 1 inhibitor | 0.053 0.005 CID_154699603 | CID_154699603 | |
| 0.008 | 0.034 | 0.016 | Ileal bile acid transport inhibitor | 0.016 0.013 CID_154699603 | CID_154699603 | |
| 0.032 | 0.06 | 0.125 | Ribonucleoside-diphosphate reductase inhibitor | 0.125 0.015 CID_154699603 | CID_154699603 | |
| 0.03 | 0.063 | 0.119 | Ribonucleotide reductase inhibitor | 0.119 0.017 CID_154699603 | CID_154699603 | |
| 0.024 | 0.057 | 0.08 | Factor XIIIa inhibitor | 0.08 0.008 CID_154699603 | CID_154699603 | |
| 0.057 | 0.093 | 0.163 | Metalloproteinase-9 inhibitor | 0.163 0.013 CID_154699603 | CID_154699603 | |
| 0.026 | 0.063 | 0.442 | Glycine transporter 2 inhibitor | 0.442 0.003 CID_154699603 | CID_154699603 | |
| 0.042 | 0.079 | 0.267 | Neutrophil collagenase inhibitor | 0.267 0.005 CID_154699603 | CID_154699603 | |
| 0.023 | 0.062 | 0.271 | Toll-Like receptor 2 agonist | 0.271 0.003 CID_154699603 | CID_154699603 | |
| 0.095 | 0.134 | 0.569 | Peroxidase inhibitor | 0.569 0.005 CID_154699603 | CID_154699603 | |
| 0.087 | 0.127 | 0.159 | Cyclooxygenase 3 inhibitor | 0.159 0.041 CID_154699603 | CID_154699603 | |
| 0.036 | 0.076 | 0.065 | Cathepsin L inhibitor | 0.065 0.033 CID_154699603 | CID_154699603 | |
| 0.045 | 0.086 | 0.087 | Phenylalanine 4-hydroxylase inhibitor | 0.087 0.033 CID_154699603 | CID_154699603 | |
| 0.006 | 0.059 | 0.03 | Aminopeptidase A inhibitor | 0.03 0.006 CID_154699603 | CID_154699603 | |
| 0.037 | 0.098 | 0.079 | NMDA 2 receptor antagonist | 0.079 0.044 CID_154699603 | CID_154699603 | |
| 0.05 | 0.112 | 0.167 | Metalloproteinase-2 inhibitor | 0.167 0.015 CID_154699603 | CID_154699603 | |
| 0.053 | 0.119 | 0.08 | NMDA receptor antagonist | 0.08 0.066 CID_154699603 | CID_154699603 | |
| 0.067 | 0.134 | 0.305 | Nitric-oxide synthase inhibitor | 0.305 0.004 CID_154699603 | CID_154699603 | |
| 0.056 | 0.123 | 0.259 | Inducible nitric-oxide synthase inhibitor | 0.259 0.005 CID_154699603 | CID_154699603 | |
| 0.039 | 0.109 | 0.215 | Catalase inhibitor | 0.215 0.013 CID_154699603 | CID_154699603 | |
| 0.071 | 0.145 | 0.13 | Multidrug resistance-associated protein 1 inhibitor | 0.13 0.038 CID_154699603 | CID_154699603 | |
| 0.071 | 0.145 | 0.102 | Toll-Like receptor 4 antagonist | 0.102 0.067 CID_154699603 | CID_154699603 | |
| 0.18 | 0.255 | 0.368 | Antibacterial | 0.368 0.092 CID_154699603 | CID_154699603 | |
| 0.046 | 0.126 | 0.061 | Histone deacetylase SIRT3 inhibitor | 0.061 0.047 CID_154699603 | CID_154699603 | |
| 0.091 | 0.186 | 0.147 | Vanilloid 1 agonist | 0.147 0.041 CID_154699603 | CID_154699603 | |
| 0.014 | 0.111 | 0.033 | Calcitonin receptor agonist | 0.033 0.024 CID_154699603 | CID_154699603 | |
| 0.019 | 0.121 | 0.113 | Matrix metalloproteinase 1 inhibitor | 0.113 0.01 CID_154699603 | CID_154699603 | |
| 0.017 | 0.123 | 0.041 | Carboxypeptidase B inhibitor | 0.041 0.012 CID_154699603 | CID_154699603 | |
| 0.016 | 0.123 | 0.047 | Oxytocin agonist | 0.047 0.025 CID_154699603 | CID_154699603 | |
| 0.035 | 0.144 | 0.053 | DNA helicase inhibitor | 0.053 0.042 CID_154699603 | CID_154699603 | |
| 0.139 | 0.255 | 0.176 | Neuropeptide Y2 antagonist | 0.176 0.168 CID_154699603 | CID_154699603 | |
| 0.155 | 0.274 | 0.44 | Histamine release inhibitor | 0.44 0.055 CID_154699603 | CID_154699603 | |
| 0.027 | 0.152 | 0.071 | Carbonic anhydrase stimulant | 0.071 0.031 CID_154699603 | CID_154699603 | |
| 0.077 | 0.207 | 0.2 | Cell wall synthesis inhibitor | 0.2 0.03 CID_154699603 | CID_154699603 | |
| 0.129 | 0.263 | 0.311 | Peptidyltransferase inhibitor | 0.311 0.021 CID_154699603 | CID_154699603 | |
| 0.127 | 0.262 | 0.219 | Gastrin inhibitor | 0.219 0.12 CID_154699603 | CID_154699603 | |
| 0.137 | 0.285 | 0.374 | Insulysin inhibitor | 0.374 0.027 CID_154699603 | CID_154699603 | |
| 0.023 | 0.173 | 0.043 | VCAM-1 antagonist | 0.043 0.018 CID_154699603 | CID_154699603 | |
| 0.023 | 0.173 | 0.043 | VCAM antagonist | 0.043 0.018 CID_154699603 | CID_154699603 | |
| 0.024 | 0.179 | 0.181 | Matrix metalloproteinase inhibitor | 0.181 0.01 CID_154699603 | CID_154699603 | |
| 0.004 | 0.163 | 0.068 | Arginase inhibitor | 0.068 0.008 CID_154699603 | CID_154699603 | |
| 0.05 | 0.225 | 0.238 | Mucolytic | 0.238 0.008 CID_154699603 | CID_154699603 | |
| 0.017 | 0.194 | 0.048 | Maillard reaction inhibitor | 0.048 0.045 CID_154699603 | CID_154699603 | |
| 0.019 | 0.199 | 0.05 | Bombesin antagonist | 0.05 0.029 CID_154699603 | CID_154699603 | |
| 0.019 | 0.2 | 0.047 | Neurotensin receptor antagonist | 0.047 0.03 CID_154699603 | CID_154699603 | |
| 0.034 | 0.224 | 0.069 | Caspase 9 inhibitor | 0.069 0.032 CID_154699603 | CID_154699603 | |
| 0.077 | 0.269 | 0.142 | Interleukin 6 antagonist | 0.142 0.103 CID_154699603 | CID_154699603 | |
| 0.055 | 0.253 | 0.245 | Toll-Like receptor 2 antagonist | 0.245 0.01 CID_154699603 | CID_154699603 | |
| 0.153 | 0.353 | 0.262 | Apoptosis agonist | 0.262 0.202 CID_154699603 | CID_154699603 | |
| 0.017 | 0.223 | 0.068 | Neuropeptide agonist | 0.068 0.035 CID_154699603 | CID_154699603 | |
| 0.013 | 0.222 | 0.073 | Aminopeptidase N inhibitor | 0.073 0.019 CID_154699603 | CID_154699603 | |
| 0.072 | 0.284 | 0.581 | Immunostimulant | 0.581 0.019 CID_154699603 | CID_154699603 | |
| 0.011 | 0.225 | 0.057 | Metalloproteinase-3 inhibitor | 0.057 0.026 CID_154699603 | CID_154699603 | |
| 0.049 | 0.267 | 0.148 | Protein-tyrosine phosphatase inhibitor | 0.148 0.08 CID_154699603 | CID_154699603 | |
| 0.032 | 0.254 | 0.23 | Expectorant | 0.23 0.015 CID_154699603 | CID_154699603 | |
| 0.031 | 0.256 | 0.152 | Protease inhibitor | 0.152 0.029 CID_154699603 | CID_154699603 | |
| 0.037 | 0.266 | 0.109 | Aminoacyl-tRNA synthetase inhibitor | 0.109 0.037 CID_154699603 | CID_154699603 | |
| 0.019 | 0.249 | 0.093 | Aminopeptidase microsomal inhibitor | 0.093 0.019 CID_154699603 | CID_154699603 | |
| 0.008 | 0.239 | 0.031 | Calcium-sensing receptor agonist | 0.031 0.012 CID_154699603 | CID_154699603 | |
| 0.015 | 0.251 | 0.061 | Matrix metalloproteinase (membrane-type) inhibitor | 0.061 0.032 CID_154699603 | CID_154699603 | |
| 0.025 | 0.267 | 0.064 | Vanilloid 2 antagonist | 0.064 0.019 CID_154699603 | CID_154699603 | |
| 0.065 | 0.321 | 0.23 | Free radical scavenger | 0.23 0.078 CID_154699603 | CID_154699603 | |
| 0.084 | 0.39 | 0.31 | Antithrombotic | 0.31 0.082 CID_154699603 | CID_154699603 | |
| 0.084 | 0.396 | 0.142 | Catenin beta inhibitor | 0.142 0.126 CID_154699603 | CID_154699603 | |
| 0.003 | 0.347 | 0.03 | VLA-4 antagonist | 0.03 0.017 CID_154699603 | CID_154699603 | |
| 0.005 | 0.354 | 0.064 | Prostacyclin antagonist | 0.064 0.008 CID_154699603 | CID_154699603 | |
| 0.024 | 0.389 | 0.064 | Trypsin inhibitor | 0.064 0.039 CID_154699603 | CID_154699603 | |
| 0.025 | 0.393 | 0.06 | Cathepsin E inhibitor | 0.06 0.041 CID_154699603 | CID_154699603 | |
| 0.003 | 0.373 | 0.025 | Aminopeptidase P inhibitor | 0.025 0.015 CID_154699603 | CID_154699603 | |
| 0.006 | 0.391 | 0.03 | Caspase 2 inhibitor | 0.03 0.023 CID_154699603 | CID_154699603 | |
| 0.011 | 0.398 | 0.102 | Angiotensin-converting enzyme inhibitor | 0.102 0.008 CID_154699603 | CID_154699603 | |
| 0.025 | 0.419 | 0.361 | Thrombolytic | 0.361 0.015 CID_154699603 | CID_154699603 | |
| 0.002 | 0.4 | 0.034 | Neutral endopeptidase inhibitor | 0.034 0.01 CID_154699603 | CID_154699603 | |
| 0.007 | 0.426 | 0.034 | Growth factor receptor-bound protein 2 antagonist | 0.034 0.026 CID_154699603 | CID_154699603 | |
| 0.014 | 0.456 | 0.074 | Cathepsin B inhibitor | 0.074 0.027 CID_154699603 | CID_154699603 | |
| 0.034 | 0.486 | 0.137 | Transcription factor NF kappa B stimulant | 0.137 0.019 CID_154699603 | CID_154699603 | |
| 0.001 | 0.466 | 0.023 | N-Acetylated alpha-linked acidic dipeptidase inhibitor | 0.023 0.006 CID_154699603 | CID_154699603 | |
| 0.026 | 0.49 | 0.453 | Angiogenesis stimulant | 0.453 0.015 CID_154699603 | CID_154699603 | |
| 0.028 | 0.501 | 0.377 | Platelet antagonist | 0.377 0.032 CID_154699603 | CID_154699603 | |
| 0.005 | 0.486 | 0.041 | HIV-1 protease inhibitor | 0.041 0.033 CID_154699603 | CID_154699603 | |
| 0.01 | 0.503 | 0.045 | Farnesyltransferase inhibitor | 0.045 0.034 CID_154699603 | CID_154699603 | |
| 0.04 | 0.552 | 0.314 | Hepatoprotectant | 0.314 0.026 CID_154699603 | CID_154699603 | |
| 0.029 | 0.546 | 0.267 | Antioxidant | 0.267 0.075 CID_154699603 | CID_154699603 | |
| 0.011 | 0.538 | 0.045 | Neurokinin 2 agonist | 0.045 0.024 CID_154699603 | CID_154699603 | |
| 0.025 | 0.566 | 0.187 | Antiamyloidogenic | 0.187 0.109 CID_154699603 | CID_154699603 | |
| 0.021 | 0.577 | 0.54 | Interleukin antagonist | 0.54 0.017 CID_154699603 | CID_154699603 | |
| 0.035 | 0.606 | 0.23 | Immunosuppressant | 0.23 0.166 CID_154699603 | CID_154699603 | |
| 0.012 | 0.584 | 0.044 | Glutamate (mGluR8) antagonist | 0.044 0.013 CID_154699603 | CID_154699603 | |
| 0.008 | 0.595 | 0.171 | Erythropoietin receptor agonist | 0.171 0.007 CID_154699603 | CID_154699603 | |
| 0.014 | 0.605 | 0.113 | Factor XII inhibitor | 0.113 0.028 CID_154699603 | CID_154699603 | |
| 0.003 | 0.599 | 0.156 | Leukotriene A4 hydrolase inhibitor | 0.156 0.005 CID_154699603 | CID_154699603 | |
| 0.003 | 0.614 | 0.073 | GP IIb/IIIa receptor antagonist | 0.073 0.023 CID_154699603 | CID_154699603 | |
| 0.005 | 0.622 | 0.051 | Endothelin-converting enzyme inhibitor | 0.051 0.03 CID_154699603 | CID_154699603 | |
| 0.04 | 0.663 | 0.337 | Growth hormone agonist | 0.337 0.025 CID_154699603 | CID_154699603 | |
| 0.02 | 0.674 | 0.229 | Histone deacetylase SIRT1 inhibitor | 0.229 0.022 CID_154699603 | CID_154699603 | |
| 0.007 | 0.672 | 0.053 | Plasminogen activator inhibitor | 0.053 0.045 CID_154699603 | CID_154699603 | |
| 0.005 | 0.672 | 0.07 | Analgesic, opioid | 0.07 0.061 CID_154699603 | CID_154699603 | |
| 0.005 | 0.682 | 0.05 | Integrin alpha5beta1 antagonist | 0.05 0.017 CID_154699603 | CID_154699603 | |
| 0.009 | 0.69 | 0.09 | Sirtuin 1 inhibitor | 0.09 0.028 CID_154699603 | CID_154699603 | |
| 0.012 | 0.703 | 0.065 | Bombesin 1 receptor agonist | 0.065 0.035 CID_154699603 | CID_154699603 | |
| 0.013 | 0.714 | 0.087 | Somatostatin 1 agonist | 0.087 0.044 CID_154699603 | CID_154699603 | |
| 0.01 | 0.716 | 0.196 | Chelator | 0.196 0.025 CID_154699603 | CID_154699603 | |
| 0.004 | 0.718 | 0.04 | Kinesin-like protein 1 inhibitor | 0.04 0.022 CID_154699603 | CID_154699603 | |
| 0.004 | 0.718 | 0.04 | Kinesin antagonist | 0.04 0.022 CID_154699603 | CID_154699603 | |
| 0.016 | 0.733 | 0.088 | Adenine nucleotide translocase inhibitor | 0.088 0.006 CID_154699603 | CID_154699603 | |
| 0.005 | 0.73 | 0.046 | Carbonic anhydrase I stimulant | 0.046 0.018 CID_154699603 | CID_154699603 | |
| 0.007 | 0.736 | 0.073 | Cell adhesion molecule inhibitor | 0.073 0.065 CID_154699603 | CID_154699603 | |
| 0.016 | 0.759 | 0.182 | Nav1.4 sodium channel blocker | 0.182 0.023 CID_154699603 | CID_154699603 | |
| 0.009 | 0.755 | 0.046 | Cathepsin F inhibitor | 0.046 0.018 CID_154699603 | CID_154699603 | |
| 0.035 | 0.782 | 0.413 | Sodium/bile acid cotransporter inhibitor | 0.413 0.014 CID_154699603 | CID_154699603 | |
| 0.004 | 0.752 | 0.073 | Integrin antagonist | 0.073 0.021 CID_154699603 | CID_154699603 | |
| 0.005 | 0.763 | 0.079 | Thrombin inhibitor | 0.079 0.043 CID_154699603 | CID_154699603 | |
| 0.008 | 0.771 | 0.045 | Cholecystokinin B agonist | 0.045 0.019 CID_154699603 | CID_154699603 | |
| 0.028 | 0.796 | 0.129 | Folate antagonist | 0.129 0.032 CID_154699603 | CID_154699603 | |
| 0.006 | 0.791 | 0.042 | Growth hormone release inhibitor | 0.042 0.029 CID_154699603 | CID_154699603 | |
| 0.003 | 0.801 | 0.04 | Cholecystokinin antagonist | 0.04 0.03 CID_154699603 | CID_154699603 | |
| 0.019 | 0.838 | 0.325 | Hematopoietic | 0.325 0.005 CID_154699603 | CID_154699603 | |
| 0.012 | 0.835 | 0.057 | Carbonic anhydrase II stimulant | 0.057 0.027 CID_154699603 | CID_154699603 | |
| 0.008 | 0.835 | 0.113 | Cell adhesion inhibitor | 0.113 0.072 CID_154699603 | CID_154699603 | |
| 0.005 | 0.832 | 0.115 | Neurotrophic factor | 0.115 0.103 CID_154699603 | CID_154699603 | |
| 0.012 | 0.853 | 0.231 | Platelet adhesion inhibitor | 0.231 0.056 CID_154699603 | CID_154699603 | |
| 0.005 | 0.85 | 0.032 | Somatostatin 5 agonist | 0.032 0.028 CID_154699603 | CID_154699603 | |
| 0.004 | 0.857 | 0.093 | Selectin antagonist | 0.093 0.03 CID_154699603 | CID_154699603 | |
| 0.004 | 0.862 | 0.054 | Macrophage elastase inhibitor | 0.054 0.022 CID_154699603 | CID_154699603 | |
| 0.002 | 0.869 | 0.064 | Complement C3a chemotactic receptor antagonist | 0.064 0.02 CID_154699603 | CID_154699603 | |
| 0.003 | 0.874 | 0.031 | Bradykinin B2 receptor agonist | 0.031 0.017 CID_154699603 | CID_154699603 | |
| 0.017 | 0.914 | 0.34 | Apoptosis antagonist | 0.34 0.061 CID_154699603 | CID_154699603 | |
| 0.003 | 0.909 | 0.096 | Glucagon-like peptide 1 agonist | 0.096 0.024 CID_154699603 | CID_154699603 | |
| 0.002 | 0.913 | 0.031 | Renin inhibitor | 0.031 0.03 CID_154699603 | CID_154699603 | |
| 0.003 | 0.939 | 0.074 | Prostaglandin EP2 antagonist | 0.074 0.03 CID_154699603 | CID_154699603 | |
| 0.004 | 0.949 | 0.244 | Anticoagulant | 0.244 0.04 CID_154699603 | CID_154699603 | |
| 0.005 | 0.966 | 0.169 | Bone formation stimulant | 0.169 0.047 CID_154699603 | CID_154699603 | |
| 0.005 | 0.981 | 0.388 | Immunomodulator | 0.388 0.048 CID_154699603 | CID_154699603 | |
| 0.002 | 0.992 | 0.031 | Protocollagen prolyl hydroxylase inhibitor | 0.031 0.014 CID_154699603 | CID_154699603 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |